WINTON GROUP Ltd Raises Stake in Privia Health Group, Inc. (NASDAQ:PRVA)

WINTON GROUP Ltd boosted its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 1.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 60,607 shares of the company’s stock after acquiring an additional 902 shares during the period. WINTON GROUP Ltd owned about 0.05% of Privia Health Group worth $1,185,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the company. First Horizon Advisors Inc. grew its stake in shares of Privia Health Group by 53.8% during the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after purchasing an additional 632 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in Privia Health Group by 7,833.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock worth $47,000 after buying an additional 2,350 shares during the last quarter. Financial Management Professionals Inc. acquired a new position in shares of Privia Health Group during the 4th quarter worth about $51,000. Quarry LP increased its holdings in shares of Privia Health Group by 344.6% in the 3rd quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after acquiring an additional 2,533 shares during the last quarter. Finally, Neo Ivy Capital Management acquired a new stake in shares of Privia Health Group during the 3rd quarter worth about $66,000. 94.48% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts recently issued reports on PRVA shares. Macquarie started coverage on Privia Health Group in a report on Monday, December 16th. They issued an “outperform” rating and a $25.00 price target for the company. Stephens restated an “overweight” rating and issued a $26.00 target price on shares of Privia Health Group in a report on Thursday, January 2nd. Needham & Company LLC reiterated a “buy” rating and set a $30.00 price target on shares of Privia Health Group in a research note on Friday, March 21st. Canaccord Genuity Group upped their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, February 28th. Finally, JMP Securities set a $29.00 target price on Privia Health Group in a research report on Friday, February 28th. One research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $26.67.

Privia Health Group Stock Down 1.4 %

Shares of Privia Health Group stock opened at $22.59 on Friday. The firm has a market cap of $2.72 billion, a price-to-earnings ratio of 225.92, a price-to-earnings-growth ratio of 3.47 and a beta of 0.85. Privia Health Group, Inc. has a 52-week low of $15.92 and a 52-week high of $26.04. The company’s 50-day simple moving average is $23.80 and its 200-day simple moving average is $21.16.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.